Several studies have established NEIL3-related survival and prognostic models, providing new diagnostic and treatment strategies for NSCLC (Zhao et al., 2022; Ali et al., 2022; Zhao et al., 2021a; Ömeroğlu Şimşek et al., 2020). Here, NEIL3 is linked to non-small cell lung carcinoma.